Article Details
Retrieved on: 2017-12-22 15:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Rexahn Pharmaceuticals logo <b>Vanguard Group</b> Inc. cut its stake in Rexahn Pharmaceuticals, Inc. (NYSEAMERICAN:RNN) by 83.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 841,146 shares of the ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here